絞り込み

16533

広告

Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.

著者 Horikawa Y , Mizutamari H , Mimori N , Kato Y , Fushimi S , Sato S , Okubo S
Scand J Gastroenterol.2017 Dec 07 ; ():1-9.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (180view , 0users)

Full Text Sources

Miscellaneous

Endoscopic submucosal dissection (ESD) is a promising method for the resection of superficial gastric neoplasms. Vonoprazan is a novel potassium-competitive acid blocker (P-CAB) that is currently considered as a potential alternative to proton pump inhibitors (PPIs) for the treatment of acid-related diseases. However, the utility of vonoprazan in ESD-related ulcers is unclear. Therefore, we compared the short-term efficacies of vonoprazan and the PPI lansoprazole in ESD-related ulcer healing during the first two weeks following intervention.
PMID: 29214885 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード